Pregled bibliografske jedinice broj: 1053076
In vitro susceptibility to antibiotics of Escherichia coli isolates in community acquired urinary tract infections
In vitro susceptibility to antibiotics of Escherichia coli isolates in community acquired urinary tract infections // Clin Microbiol Infect
Stockholm, Švedska, 2000. str. 97-98 (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 1053076 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
In vitro susceptibility to antibiotics of Escherichia coli isolates in community acquired urinary tract infections
Autori
Barišić, Zvonimir ; Babić-Erceg, Andrea ; Borzić, Elmica ; Carev, Merica ; Kaliterna, Vanja ; Zoranić, Vinko ; Smoljanović, Mladen
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Clin Microbiol Infect
/ - , 2000, 97-98
Skup
10th European Congress of Clinical Microbiology and Infection
Mjesto i datum
Stockholm, Švedska, 28.05.2000. - 31.05.2000
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Escherichia coli ; antibiotics
Sažetak
Objectives: To determine in vitro susceptibility of E. coli isolates in community acquired urinary tract infections (CA-UTI) and to suggest optimal empirical antibiotic therapy in these patients. Methods: Three hundred fifthy seven consecutive strains of E. coli isolated from patients with CA-UTI were included in this study. Isolation and identification were performed by standard method and susceptibillity testing was performed by disk diffusion method. Susceptibillity was tested to amoxycillin (AMX), amoxycillin-clavulanate (AMC), cephalexin (CN), cefuroxime (CXM), ceftibuten (CTB), trimethoprim-sulfamethoxazole (STX) and ciprofloxacin (CIP). Results: From total number of 357 strains of E. coli 44.32% were resistant to AMX, 3.92% to AMC, 4.76% to CN, 2.24% to CXM, 0.84% to CTB, 17.09% to STX and 1.77% strains were resistant to ClP. Conclusions: The best in vitro susceptibillity was shown for ceftibuten, followed by ciproftoxacin and cefuroxime. Strains of E. coli show high resistance rate to trimethoprim-sulfamethoxazole and amoxycillin. The antibiotic of the best choice for empirical antibiotic therapy in patients with CA-UTI in our region is ceftibuten. Drugs like trimethaprim-sulphametoxazol or amoxycillin, most often prescribed in empirical therapy of CA-UTI, are not a good choice, because strains of E. coli show high rate of in vitro resistance to these antibiotics.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Profili:
Andrea Babić-Erceg
(autor)
Mladen Smoljanović
(autor)
Vanja Kaliterna
(autor)
Elmica Borzić
(autor)
Zvonimir Barišić
(autor)